Skip to main content
Clinical Trials/NCT03864718
NCT03864718CompletedNot Applicable

Efficacy of Photodynamic Therapy and Intra-lesional 5-wing in Complex Perianal Fistula

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana0 sites49 target enrollmentStarted: January 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
49
Primary Endpoint
Healing

Study Overview

Brief Summary

Objective: Validate and analyze the results of intralesional photodynamic therapy in the treatment of complex anal fistula.

Methods: Prospective observational study including patients treated for complex anal fistula who underwent intralesional photodynamic therapy (i-PDT). Patients were included with a minimum follow up of 1-year, in order to evaluate recurrence, continence and postoperative morbidity. Intralesional 5-aminolevulinic acid gel 2% was directly injected into the fistula. The internal and external orifices were closed. After an incubation period of 2 h, the fistula was irradiated using an optical fibre connected to a red laser (MULTIDIODE 630 PDT, INTERmedic, Spain) operating at 1 W/ cm for 3 min (180 Joules).

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • complex anal fistula according to Parks classification

Exclusion Criteria

  • Non cryptoglandular fistulas
  • acute sepsis
  • inflammatory bowel diseases
  • simple fistulas (defined as subcutaneous, intersphincteric and low transsphincteric fistula)
  • pregnant patients
  • patients <18
  • immunocompromised
  • patients who refused consent.

Outcomes

Primary Outcomes

Healing

Time Frame: 12 months after surgery

Yes/Not

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Antonio Arroyo Sebastian

Principal Investigator

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Similar Trials